PHARMACOGENETIC MARKERS FOR PREDICTING AN EFFECTIVE RESPONSE TO BISPHOSPHONATES WHEN PLANNING TREATMENT FOR POSTMENOPAUSAL OSTEOPOROSIS

E. V. Rudenko; V. Alekna; E. V. Rudenko; M. Tamulaitiene; O. Yu. Samokhovets; E. V. Kobets; P. M. Morozik

doi:10.14341/osteo12865-9971

For citations:

Rudenko E.V., Alekna V., Rudenko E.V., Tamulaitiene M., Samokhovets O.Yu., Kobets E.V., Morozik P.M. PHARMACOGENETIC MARKERS FOR PREDICTING AN EFFECTIVE RESPONSE TO BISPHOSPHONATES WHEN PLANNING TREATMENT FOR POSTMENOPAUSAL OSTEOPOROSIS. Osteoporosis and Bone Diseases. 2020;23(2):147-148. (In Russ.)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 2072-2680 (Print)
ISSN 2311-0716 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Osteoporosis and Bone Diseases

For citations:

Cookies policy